{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:37:24Z","timestamp":1790246244123,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T00:00:00Z","timestamp":1588896000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T00:00:00Z","timestamp":1588896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004320","name":"Shiraz University of Medical Sciences","doi-asserted-by":"publisher","award":["95-01-32-12334"],"award-info":[{"award-number":["95-01-32-12334"]}],"id":[{"id":"10.13039\/501100004320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00262-020-02591-y","type":"journal-article","created":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T07:02:42Z","timestamp":1588921362000},"page":"1917-1928","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Aberrant peripheral blood CD4+ CD25+ FOXP3+ regulatory T cells\/T helper-17 number is associated with the outcome of patients with lymphoma"],"prefix":"10.1007","volume":"69","author":[{"given":"Mehdi","family":"Dehghani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Kalani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Golmoghaddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mani","family":"Ramzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6489-0979","authenticated-orcid":false,"given":"Nargess","family":"Arandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,8]]},"reference":[{"key":"2591_CR1","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/S0140-6736(12)60605-9","volume":"380","author":"KR Shankland","year":"2012","unstructured":"Shankland KR, Armitage JO, Hancock BW (2012) Non-hodgkin lymphoma. The Lancet 380:848\u2013857","journal-title":"The Lancet"},{"key":"2591_CR2","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.7314\/APJCP.2015.16.8.3551","volume":"16","author":"M Dehghani","year":"2015","unstructured":"Dehghani M, Haddadi S, Vojdani R (2015) Signs, symptoms and complications of non-Hodgkin\u2019s lymphoma according to grade and stage in South Iran. Asian Pac J Cancer Prev 16:3551\u20133557","journal-title":"Asian Pac J Cancer Prev"},{"key":"2591_CR3","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3389\/fonc.2018.00288","volume":"8","author":"D Kumar","year":"2018","unstructured":"Kumar D, Xu ML (2018) Microenvironment cell contribution to lymphoma immunity. Front Oncol 8:288","journal-title":"Front Oncol"},{"key":"2591_CR4","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.3324\/haematol.2017.184192","volume":"103","author":"M De Charette","year":"2018","unstructured":"De Charette M, Houot R (2018) Hide or defend, the two strategies of lymphoma immune evasion: potential implications for immunotherapy. Haematologica 103:1256\u20131268","journal-title":"Haematologica"},{"key":"2591_CR5","doi-asserted-by":"publisher","first-page":"1832968","DOI":"10.1155\/2017\/1832968","volume":"2017","author":"G D\u2019Arena","year":"2017","unstructured":"D\u2019Arena G, Vitale C, Coscia M et al (2017) Regulatory T cells and their prognostic relevance in hematologic malignancies. J Immunol Res 2017:1832968","journal-title":"J Immunol Res"},{"key":"2591_CR6","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1158\/1078-0432.CCR-06-2363","volume":"13","author":"N Kobayashi","year":"2007","unstructured":"Kobayashi N, Hiraoka N, Yamagami W, Ojima H, Kanai Y, Kosuge T, Nakajima A, Hirohashi S (2007) FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis. Clin Cancer Res 13:902\u2013911","journal-title":"Clin Cancer Res"},{"key":"2591_CR7","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/nm1093","volume":"10","author":"TJ Curiel","year":"2004","unstructured":"Curiel TJ, Coukos G, Zou L et al (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10:942","journal-title":"Nat Med"},{"key":"2591_CR8","doi-asserted-by":"publisher","first-page":"5373","DOI":"10.1200\/JCO.2006.05.9584","volume":"24","author":"GJ Bates","year":"2006","unstructured":"Bates GJ, Fox SB, Han C, Leek RD, Garcia JF, Harris AL, Banham AH (2006) Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J Clin Oncol 24:5373\u20135380","journal-title":"J Clin Oncol"},{"key":"2591_CR9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1756-8722-4-50","volume":"4","author":"J Wang","year":"2011","unstructured":"Wang J, Ke X-Y (2011) The four types of Tregs in malignant lymphomas. J Hematol Oncol 4:50","journal-title":"J Hematol Oncol"},{"key":"2591_CR10","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1365-2567.2011.03539.x","volume":"135","author":"CA Lindqvist","year":"2012","unstructured":"Lindqvist CA, Loskog AS (2012) T regulatory cells in B-cell malignancy\u2013tumour support or kiss of death? Immunology 135:255\u2013260","journal-title":"Immunology"},{"key":"2591_CR11","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1517\/14728222.12.6.769","volume":"12","author":"C Koenecke","year":"2008","unstructured":"Koenecke C, Ukena SN, Ganser A, Franzke A (2008) Regulatory T cells as therapeutic target in Hodgkin\u2019s lymphoma. Expert Opin Ther Targets 12:769\u2013782","journal-title":"Expert Opin Ther Targets"},{"key":"2591_CR12","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1182\/blood-2006-04-018218","volume":"108","author":"J Carreras","year":"2006","unstructured":"Carreras J, Lopez-Guillermo A, Fox BC, Colomo L, Martinez A, Roncador G, Montserrat E, Campo E, Banham AH (2006) High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma. Blood 108:2957\u20132964","journal-title":"Blood"},{"key":"2591_CR13","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1200\/JCO.2008.18.0513","volume":"27","author":"J Carreras","year":"2009","unstructured":"Carreras J, Lopez-Guillermo A, Roncador G et al (2009) High numbers of tumor-infiltrating programmed cell death 1\u2013positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma. J Clin Oncol 27:1470\u20131476","journal-title":"J Clin Oncol"},{"key":"2591_CR14","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1309\/AJCPUJGMVV6ZF4GG","volume":"144","author":"C Chang","year":"2015","unstructured":"Chang C, Wu S-Y, Kang Y-W, Lin K-P, Chen T-Y, Medeiros LJ, Chang K-C (2015) High levels of regulatory T cells in blood are a poor prognostic factor in patients with diffuse large B-cell lymphoma. Am J Clin Pathol 144:935\u2013944","journal-title":"Am J Clin Pathol"},{"key":"2591_CR15","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1007\/s12032-012-0176-1","volume":"29","author":"M Dehghani","year":"2012","unstructured":"Dehghani M, Sharifpour S, Amirghofran Z, Zare HR (2012) Prognostic significance of T cell subsets in peripheral blood of B cell non-Hodgkin\u2019s lymphoma patients. Med Oncol 29:2364\u20132371","journal-title":"Med Oncol"},{"key":"2591_CR16","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/ejh.12144","volume":"91","author":"M G\u0142owala-Kosi\u0144ska","year":"2013","unstructured":"G\u0142owala-Kosi\u0144ska M, Chwieduk A, Nieckula J, Sadu\u015b-Wojciechowska M, Grosicki S, Rusin A, Nowara E, Giebel S (2013) Association of circulating regulatory T cell number with the incidence and prognosis of diffuse large B-cell lymphoma. Eur J Haematol 91:122\u2013128","journal-title":"Eur J Haematol"},{"key":"2591_CR17","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/10428190701824536","volume":"49","author":"N-R Lee","year":"2008","unstructured":"Lee N-R, Song E-K, Jang KY, Choi HN, Moon WS, Kwon K, Lee J-H, Yim C-Y, Kwak J-Y (2008) Prognostic impact of tumor infiltrating FOXP3 positive regulatory T cells in diffuse large B-cell lymphoma at diagnosis. Leuk Lymphoma 49:247\u2013256","journal-title":"Leuk Lymphoma"},{"key":"2591_CR18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3324\/haematol.11702","volume":"93","author":"A Tzankov","year":"2008","unstructured":"Tzankov A, Meier C, Hirschmann P, Went P, Pileri SA, Dirnhofer S (2008) Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin\u2019s lymphoma. Haematologica 93:193\u2013200","journal-title":"Haematologica"},{"key":"2591_CR19","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1084\/jem.20070663","volume":"204","author":"F Annunziato","year":"2007","unstructured":"Annunziato F, Cosmi L, Santarlasci V et al (2007) Phenotypic and functional features of human Th17 cells. J Exp Med 204:1849\u20131861","journal-title":"J Exp Med"},{"key":"2591_CR20","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.cca.2011.01.015","volume":"412","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Ma D, Zhang Y, Tian Y, Wang X, Qiao Y, Cui B (2011) The imbalance of Th17\/Treg in patients with uterine cervical cancer. Clin Chim Acta 412:894\u2013900","journal-title":"Clin Chim Acta"},{"key":"2591_CR21","doi-asserted-by":"publisher","first-page":"6730","DOI":"10.4049\/jimmunol.178.11.6730","volume":"178","author":"I Kryczek","year":"2007","unstructured":"Kryczek I, Wei S, Zou L, Altuwaijri S, Szeliga W, Kolls J, Chang A, Zou W (2007) Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J Immunol 178:6730\u20136733","journal-title":"J Immunol"},{"key":"2591_CR22","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1182\/blood-2009-03-208249","volume":"114","author":"I Kryczek","year":"2009","unstructured":"Kryczek I, Banerjee M, Cheng P et al (2009) Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood 114:1141\u20131149","journal-title":"Blood"},{"key":"2591_CR23","doi-asserted-by":"publisher","first-page":"3254","DOI":"10.1158\/1078-0432.CCR-07-5164","volume":"14","author":"KS Sfanos","year":"2008","unstructured":"Sfanos KS, Bruno TC, Maris CH, Xu L, Thoburn CJ, DeMarzo AM, Meeker AK, Isaacs WB, Drake CG (2008) Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing. Clin Cancer Res 14:3254\u20133261","journal-title":"Clin Cancer Res"},{"key":"2591_CR24","doi-asserted-by":"publisher","first-page":"e0148044","DOI":"10.1371\/journal.pone.0148044","volume":"11","author":"T Lu","year":"2016","unstructured":"Lu T, Yu S, Liu Y, Yin C, Ye J, Liu Z, Ma D, Ji C (2016) Aberrant circulating Th17 cells in patients with B-cell Non-Hodgkin\u2019s Lymphoma. PLoS ONE 11:e0148044","journal-title":"PLoS ONE"},{"key":"2591_CR25","first-page":"7957","volume":"14","author":"I Hus","year":"2017","unstructured":"Hus I, Bojarska-Junak A, Kami\u0144ska M, Dobrzy\u0144ska-Rutkowska A, Szatan K, Szymczyk A, Kukie\u0142ka-Budny B, Szczepanek D, Roli\u0144ski J (2017) Imbalance in circulatory iNKT, Th17 and T regulatory cell frequencies in patients with B-cell non-Hodgkin\u2019s lymphoma. Oncol Lett 14:7957\u20137964","journal-title":"Oncol Lett"},{"key":"2591_CR26","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/cyto.b.21330","volume":"90","author":"E Gunduz","year":"2016","unstructured":"Gunduz E, Sermet S, Musmul A (2016) Peripheral blood regulatory T cell levels are correlated with some poor prognostic markers in newly diagnosed lymphoma patients. Cytometry Part B Clin Cytom 90:449\u2013454","journal-title":"Cytometry Part B Clin Cytom"},{"key":"2591_CR27","doi-asserted-by":"publisher","first-page":"4180","DOI":"10.4049\/jimmunol.175.7.4180","volume":"175","author":"HW Lim","year":"2005","unstructured":"Lim HW, Hillsamer P, Banham AH, Kim CH (2005) Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells. J Immunol 175:4180\u20134183","journal-title":"J Immunol"},{"key":"2591_CR28","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1365-2567.2011.03439.x","volume":"133","author":"CA Lindqvist","year":"2011","unstructured":"Lindqvist CA, Christiansson LH, Th\u00f6rn I et al (2011) Both CD4+ FoxP3+ and CD4+ FoxP3\u2212 T cells from patients with B-cell malignancy express cytolytic markers and kill autologous leukaemic B cells in vitro. Immunology 133:296\u2013306","journal-title":"Immunology"},{"key":"2591_CR29","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.3109\/10428194.2015.1121260","volume":"57","author":"MA Grygorowicz","year":"2016","unstructured":"Grygorowicz MA, Biernacka M, Bujko M et al (2016) Human regulatory T cells suppress proliferation of B lymphoma cells. Leuk Lymphoma 57:1903\u20131920","journal-title":"Leuk Lymphoma"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-020-02591-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-020-02591-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-020-02591-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T23:35:45Z","timestamp":1620430545000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-020-02591-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,8]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["2591"],"URL":"https:\/\/doi.org\/10.1007\/s00262-020-02591-y","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,8]]},"assertion":[{"value":"11 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declared that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed according to the ethical standards of the local Ethics Committee of Shiraz University of Medical Sciences and in compliance with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}